- Early information reveals South Africans and Zambians have a giant urge for food for the twice-yearly HIV prevention injection. However clinics don’t but have sufficient doses for everybody who desires it.
- Staying quiet may enable rumours to unfold. Selling LEN too extensively, although, may ship folks to clinics which have run out.
- Zambia is taking info to communities close to clinics that inventory LEN. South Africa says it should inform folks truthfully the place injections can be found.
- It’s a balancing act: how do you persuade folks to desire a new medication when there isn’t sufficient of it to go round?
In today’s newsletter, Ida Jooste explains that for lenacapavir to have influence, it wants demand. However provide is scarce. Sign up for our newsletter today.
How do you persuade folks to desire a new medication when there isn’t sufficient of it to go round?
That’s the issue going through the first countries rolling out lenacapavir LEN), a six-monthly HIV prevention injection.
South Africa started its roll-out at around one in 10 government clinics on 5 June.
LEN has sparked an pleasure about HIV prevention that Mitchell Warren, govt director of the HIV advocacy organisation Avac, says he hasn’t seen in three a long time.
Some consultants say it’s straightforward to grasp why. The injection offers close to complete protection against HIV and only needs to be taken twice a year.
However for now, supplies are limited, as the one doses out there to South Africa are the branded product, made by LEN’s developer, Gilead Sciences, and paid and distributed by an association with the World Fund to Battle Aids, Tuberculosis and Malaria, till generics turn out to be out there in 2027. Some African international locations additionally get doses supported by the US authorities’s Aids fund, Pepfar.
And therein lies a catch: international locations have to create sufficient demand for LEN to persuade drug makers that there will likely be a marketplace for cheaper generic variations. The larger the market, the cheaper generic LEN will likely be.
However create an excessive amount of demand now and other people may arrive at clinics solely to be advised they’ve run out of inventory.
Zambia, which started providing LEN in December with only 500 initial doses, has been making an attempt to strike this steadiness for months. On the International Aids Conference in Rio de Janeiro in July, the nation’s director of infectious ailments, Lloyd Mulenga, described throughout a panel discussion how clinics continuously run out of inventory.
South Africa, which launched later than Zambia, but on a much larger scale, is now going through lots of the similar points.
A person named Aaron walks right into a clinic
“Yesterday, I noticed one thing I’ve by no means seen earlier than,” Sister Samaria Mwale advised Bhekisisa at Chilenje Degree One Hospital in Lusaka, to which we travelled in June.
“A person referred to as Aaron walked into the clinic with seven girls from a close-by brothel.”
Aaron had realized about LEN by area staff and persuaded the ladies to return with him. He bought the injection too.
“I took them as a result of it’s for his or her safety,” he later advised Bhekisisa. “By these girls being secure, many people are secure.”
Aaron is planning to convey one other six girls to the clinic.
Mwale had additionally chosen LEN for herself. “I believed it might be very painful, however it was manageable,” she says.
However Zambia hasn’t created this curiosity by ready for folks like Aaron to stroll into clinics.
“When you simply sat right here in your good desk, nobody would come,” Mwale explains.
Well being staff and group organisations have been taking details about LEN into communities — typically actually drumming up curiosity.
However with doses scarce, a lot of the outreach has occurred near clinics the place LEN is definitely out there.
Aaron heard about LEN this manner.
It’s an try to unravel the dilemma: create demand, however create it the place you’ve gotten injections to supply.
Elmari Briedenhann, head of communication and engagement at Wits RHI, has helped develop group plans in South Africa, Zambia, Zimbabwe, Nigeria and Kenya. She says maintaining quiet about LEN as a result of provides are scarce would create one other drawback: rumours and improper info.
“If we don’t say one thing, the area goes to replenish with misinformation,” Briedenhann says.
The reply, she argues, is to inform folks what LEN is — but additionally to be trustworthy about the place and after they can get it.
“In that sense, I’m a giant fan of the reality.”
Warren compares the present state of affairs to a small restaurant whose carrots have run out: you’ll be able to’t supply carrot soup that day, it’s off the menu. As an alternative, clinics can then supply shoppers the every day HIV prevention capsule.
South Africa stocks the pill for free at nearly all government clinics.
However international locations can’t preserve LEN on a tiny menu perpetually.
To get past a rationed roll-out, Warren says, producers want proof that there will likely be sufficient demand to make giant portions of cheaper generic LEN worthwhile.
HIV consultants writing in the International Journal for Equity in Health present how producing extra doses may convey the worth down. The authors estimate that if producers produce 5–10-million doses a yr, LEN may very well be equipped for as little as $25 per particular person a yr (about R405).
In October 2024, Gilead Sciences, gave six firms licences to make generic LEN. Two Indian producers, Hetero and Dr Reddy’s, have received donor support to make it at $40 (R650) per person per year, more or less the same cost as that of the daily HIV prevention pill. Generic LEN is predicted to turn out to be out there in early 2027.
The South African authorities and the nation’s Nationwide Aids Council, Sanac, are also in the process of negotiating with Gilead for licences for local drug makers to make LEN.
SA waited as a result of it feared shedding folks’s belief
South Africa confronted the identical dilemma as Zambia earlier than giving its first LEN injection.
Fikile Ndlovu, the well being division’s deputy director basic for HIV, says the division fearful that launching with too few doses may backfire.
“One of many issues we grappled with … was having too few doses, as a result of folks would lose belief in us,” she advised Bhekisisa.
That’s why the division delayed its launch till June when it believed it had sufficient inventory for a launch — around 38 000 doses.
LEN is at present out there in 360 public health facilities, with extra to be added in phases.
However, even in South Africa, clinics have run out of inventory. In July, one in all Bhekisisa’s TikTok followers reported she was turned away at three Gauteng clinics. At Lyttelton clinic in Centurion she was requested to make a reserving first: “‘It’s essential to name on a Monday to make an appointment’, they advised me”, the younger girl advised us on TikTok.
Bhekisisa reported the incident to Ndlovu, who then did a Zoom interview with our TikTok producer to elucidate why some clinics had run out of inventory and when new inventory would arrive. She additionally broke down that LEN clinics can not ask shoppers for appointments and despatched a well being division official to the Lyttelton clinic the subsequent day to make clear the process.
Ndlovu explains: “If we’re having an trustworthy dialog, explaining the doses we’ve got, the place we’ve got them, and the constraints, that minimises uncertainty about the place and when folks can discover them.”
Getting LEN to individuals who want it most
Demand has been hanging.
Within the first six weeks, 31 297 folks began as Bhekisisa reported. Amongst folks provided a alternative between LEN and a every day HIV prevention capsule, 98.5% selected the injection.
About a third of LEN users were new to HIV prevention medication while 28% were men — nearly 3 times the proportion traditionally reached when solely the capsule was out there, Bhekisisa’s information staff’s evaluation confirmed.
However these headline figures expose one other drawback with the thought of “demand”.
Having sufficient injections within the nation doesn’t essentially imply that the individuals who want them most can get them.
Solely 705 of the primary 31 297 LEN customers had been intercourse staff, 419 had been homosexual and bisexual males, 33 individuals who inject medication and 31 had been transgender folks.
These teams, additionally referred to as key populations, have a far greater likelihood of getting HIV than the final inhabitants.
Jacqueline Pienaar of the Aurum Institute, says such teams’ low uptake isn’t as a result of they don’t need LEN.
“The problem is that [groups with a higher chance of getting HIV] don’t need to go to clinics as a result of they’re handled badly [because of discrimination against, for instance their sexuality, gender identity or profession] or have to attend 5 to 6 hours”.
Before the US government’s HIV funding cuts in 2025, the nation’s Aids programme, Pepfar, funded separate clinics with tailormade companies for high-risk teams. However most of these clinics, which were run by nongovernmental organisations, have since closed down.
It has left them with no different choice than to go to public well being clinics the place some well being staff aren’t delicate to their wants.
For such teams, making LEN out there solely at basic public clinics can flip theoretical availability into sensible inaccessibility.
So the problem isn’t merely creating sufficient demand. It’s ensuring doses are within the locations the place individuals who need them can really get them.
What Zambia’s numbers inform us
Zambia’s roll-out now covers 106 public clinics in 13 districts.
Well being officers there have tried to deal with the identical drawback South Africa faces: the stigma high-risk teams face at clinics.
“We’ve had trainings for each cadre … from the cleaners to safety guards to scientific personnel,” says Mundia Mwitumwa, an HIV prevention technical advisor at Zambia’s well being ministry.
Seven and a half months into the nation’s roll-out, 4 382 folks had began LEN in Zambia, based on well being ministry figures. Of these, nearly three-quarters — 3 137 folks — had by no means used HIV prevention medication earlier than.
Ruth Mangaa, 29, lives in Lusaka, and is amongst those that selected the injection.
She has moved from daily pills, to an injection often known as long-acting cabotegravir (South Africa doesn’t inventory it) each two months and now to twice-yearly LEN.
“I really really feel relieved,” Mangaa says. “I don’t have to go to the clinic greater than as soon as each six months or take pill refills each month.”
She now encourages mates to get the jab and corrects them after they mistake LEN for a vaccine or therapy for HIV-positive folks. “LEN is for HIV-negative folks. Prevention begins with us,” she says.
Zambia’s oldest LEN recipient thus far is 72. On the different finish are ladies as younger as 14.
Mwitumwa says moms have introduced their teenage daughters to clinics as a result of they know they’re sexually energetic and need to defend them in opposition to HIV.
We then maintain personal classes away from the guardian, Mwitumwa explains: “We are saying, ‘Do you perceive why Mother has introduced you right here? Do you agree?’”
For Mwitumwa, these conversations counsel {that a} prevention choice folks need can typically open up conversations about HIV and intercourse that had been beforehand tough to have.
The numbers have so as to add up
Again in South Africa, arithmetic stays tough.
Up to now, the nation has acquired 114 720 LEN doses (37 920 in March/April, 19 800 in Could and 57 000 in June), paid for with its World Fund grant.
Of these, 42 947 doses had been utilized by 17 August. The remainder of the 71 773 doses have all been distributed to clinics, the well being division says.
The division and Sanac are nonetheless growing a nationwide plan for creating demand for LEN.
For now, Ndlovu says the method is easy: inform folks truthfully how a lot LEN is offered and the place they will get it. If one clinic runs out whereas one other has injections sitting unused, doses will be shifted between services or districts, she says.
However shifting scarce doses round can solely take South Africa thus far. Modelling scientists say for the nation to make a significant dent in new HIV infections inside the subsequent twenty years, between one and two million people need to take LEN at least once a year.
The long-term resolution is getting thousands and thousands of LEN doses at a worth the nation can afford.
That’s why the demand-and-supply balancing act issues.
Nations want sufficient injections to satisfy the demand they’re creating. However producers of cheaper generic LEN additionally want confidence that thousands and thousands of individuals will need to produce earlier than producing it at scale.
And South Africa’s early figures counsel that urge for food is just not going to be an issue.
“If we don’t get the generics,” Ndlovu says, ”we’re going to run into critical issues.”
Further reporting by Mia Malan.
Ida Jooste is a seasoned well being and science journalist. She has labored in newsrooms in Durban, Johannesburg and Nairobi, successful greater than 20 nationwide and worldwide media awards for her work. A world coach and speaker, she led a worldwide COVID-19 media initiative and supplies journalist mentoring in all areas of well being science.
